|
CNBX CNBX Pharmaceuticals Inc 1343009 |
| Income Statement |
|
Net Income
|
2026-05-31
|
$-154,165.00 |
| Balance Sheet |
|
Current Assets
|
$12,795.00 |
|
Assets
|
$12,795.00 |
|
Current Liabilities
|
$2,672,509.00 |
|
Equity
|
$-2,659,714.00 |
|
Shares Out
|
1475768095.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-125,624.00 |
| Market Analysis |
Market Cap
|
$444.00 |
|
PB
|
0.13 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:49 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:50 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CNBX documents filed with the SEC.
CNBX Filings
Clear
